Últimas noticias sobre Xilio Therapeutics (NASDAQ:XLO) Bolsa

Xilio Therapeutics

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

Xilio Therapeutics Inc

In the current market session, Greystone Housing Impact Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHI#NYSE">GHI</a>) share price is at $11.32, after a 4.39% decrease. Over the past month, the stock spiked by 2.93%, but over the past year, it actually fell by 20.68%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1749247242_0.png" alt="Past Year Chart" />

<h3>Greystone Housing Impact P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Greystone Housing Impact has a lower P/E than the aggregate P/E of 46.57 of the Financial Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749247242_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

News

Intraday Update

Markets

P/E Ratio Insights for Greystone Housing Impact

General

Tenaris To Launch The First $600M Tranche Of Its $1.2B Share Buyback Program

Reiterates that PENN and HG Vora Are Recommending the Same Two Highly-Qualified Nominees &ndash; Johnny Hartnett and Carlos Ruisanchez &ndash; for the Two Available Director Seats at the Upcoming Annual Meeting
PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) (&quot;PENN&quot; or the &quot;Company&quot;) today made the following statement in response to the report issued today by Institutional Shareholder Services (&quot;ISS&quot;) related to the Company&#39;s 2025 Annual Meeting of Shareholders (the &quot;Annual Meeting&quot;) on June 17, 2025:
The ISS report confirms that two director seats are up for election at the 2025 Annual Meeting and that PENN and HG Vora have nominated and are recommending the same two highly-qualified candidates - Johnny Hartnett and Carlos Ruisanchez. ISS recognizes the open-mindedness with which PENN evaluated HG Vora&#39;s director candidates, noting: &quot;To its credit, the board appears to have given serious consideration to all three dissident nominees, and was open to accepting two of these nominees as its own.&quot;1 PENN encourages all shareholders to vote for Messrs. Hartnett and Ruisanchez for election and looks forward to welcoming them to the Board. Following the Annual Meeting, 75% of PENN&#39;s directors will have joined the Board since 2019.
In reaching its conclusions however, the ISS report fails to reflect a realistic view of William Clifford&#39;s candidacy. We remind shareholders that, during his time as PENN&#39;s CFO, Mr. Clifford advocated against key initiatives that were critical to succeeding in a competitive market. Following Mr. Clifford&#39;s departure in 2013 as PENN&#39;s CFO, these changes were implemented under the publicly announced P30 program and resulted in meaningful margin improvement. Further, during his interviews with PENN&#39;s Nominating and Corporate Governance Committee, Mr. Clifford demonstrated antiquated views of a rapidly changing industry, and the same posture of resistance to exploring value-generating solutions, which we believe would hinder constructive decision-making. PENN attempted multiple resolutions with HG Vora, but all of our resolution attempts were rejected. Given HG Vora&#39;s violation of its institutional waivers by multiple state gaming regulators, our ability to allow HG Vora to influence the governance of the Company beyond the evaluation of the nominees was expressly prohibited.
We appreciate the feedback and advice we have received from our shareholders in advance of this year&#39;s Annual Meeting. We want to assure shareholders that we understand and share their focus on ensuring that PENN&#39;s Board of Directors is optimally comprised to oversee the Company&#39;s execution on a strategic plan to drive shareholder value. The Board and management team remain committed to creating value for all shareholders and will continue to take actions in support of that objective.

Management

PENN

UPDATE: PENN Entertainment Responds To ISS Report; Reiterates That PENN And HG Vora Are Recommending The Same Two Nominees, Johnny Hartnett And Carlos Ruisanchez; Says Remains Committed To Creating Value For All Shareholders And Will Continue To Take Actions In Support Of That Objective

ADVB

Advanced Biomed Enters Purchase Agreement With Helena Global; To Issue And Sell Up To $25M In Common Stock

<a href="https://www.bloomberg.com/news/articles/2025-06-06/teton-capital-said-to-agitate-for-changes-at-atlantic-union-bank?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-06/teton-capital-said-to-agitate-for-changes-at-atlantic-union-bank?embedded-checkout=true</a>

'Teton Capital Said to Agitate for Changes at Atlantic Union Bank'- Bloomberg

PLTR climbs higher through the day after an alert from TradePulse in the morning
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/06205125/Screenshot-2025-06-06-at-4.49.54%E2%80%AFPM-995x1024.png" alt="" class="wp-image-14058" /></figure>
Palantir Tech. Inc. (PLTR) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:48 AM on June 6th, a significant trading signal occurred for Palantir Tech. Inc. (PLTR) as it demonstrated a Power Inflow at a price of $124.90. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Palantir's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Palantir's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for PLTR, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
The price at the time of the Power Inflow was $124.90. The returns on the High price ($128.13) and Close price ($127.72) after the Power Inflow are respectively 2.6% and 2.3%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your appetite for risk.
Past results are not indicative of future results

Equities

Technicals

Opinion

Signals

Trading Ideas

PLTR

Palantir Rises 2.6% After Key Trading Signal

Morningstar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NASDAQ">MORN</a>) has outperformed the market over the past 20 years by 22.83% on an annualized basis producing an average annual return of 31.17%. Currently, Morningstar has a market capitalization of $13.36 billion. 
Buying $100 In MORN: If an investor had bought $100 of MORN stock 20 years ago, it would be worth $23,251.58 today based on a price of $312.38 for MORN at the time of writing.
<h3>Morningstar's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749245429_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MORN

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Offerings

PLUG

Plug Power Files For Resale From Time To Time Of 55M Shares Of Common Stock Offered By Selling Stockholder

ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) reported quarterly losses of $(0.09) per share. This is a 12.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $250.00 thousand in sales this quarter. This is a 25.00 percent increase over sales of $200.00 thousand the same period last year.

Earnings

ZBAI

ATIF Holdings Q3 EPS $(0.09) Down From $(0.08) YoY, Sales $250.00K Up From $200.00K YoY

A feud between Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk and President Donald Trump could end Musk's ties with the White House — a development <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">welcomed by Tesla protestors</a>.
However, "the job is definitely not done,&#8221; volunteer organizer Adam Sheridan tells Benzinga.
<h3 class="wp-block-heading">Feud Comes Quicker Than Anticipated</h3>
"There was a time limit on this relationship between them," Sheridan says. 
Sheridan is a volunteer organizer with the Cooper River Indivisible <a href="https://www.cooperriverindivisible.org/" target="_blank" rel="noreferrer noopener">non-profit</a> that participates in Tesla Takedown protests.
Musk and Trump were on the same side for an election. Once that was over, there was an expiration day for their relationship, the Tesla protest organizer explained.
"I think it was predictable, but still <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45805173/musk-vs-trump-tesla-suffers-record-152b-one-day-crash-as-ceo-warns-tariffs-will-cause-a-recession">quicker [than expected],</a>&#8221; Sheridan adds.
Read Also: <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">Trump Says Musk Has &#8216;Trump Derangement Syndrome&#8217; As Battle Over Bill Heats Up: &#8216;Had A Great Relationship… Don&#8217;t Know If We Will Anymore&#8217;</a>
<h3 class="wp-block-heading">Tesla Takedown Job Not Over</h3>
Sheridan said it's too early to tell if Musk is done with the White House. The Tesla protest organizer predicts Musk will still wield political influence. 
"I think he still has a lot of power,&#8221; Sheridan says. Musk&#8217;s ownership of X, he adds, allows him to control the narrative.
"[The] White House can't ignore him."
Sheridan said Trump is an emotional guy who governs on feelings, unlike other presidents who may not have gone after Musk or his companies.
"Trump really does have an ability to hurt Elon's businesses."
For example, Trump could be "detrimental" to Musk's businesses if he follows through on <a href="https://www.benzinga.com/news/space/25/06/45808621/after-threatening-to-scrap-dragon-spacecraft-amid-tussle-with-trump-musk-backs-down-following-social-media-plea-good-advice">cutting government contracts</a>, Sheridan added.
But getting Musk out of the White House was just 50% of Tesla Takedown&#8217;s goal.
Sheridan said there will be protests at Tesla dealerships on June 28, which is Musk's birthday. There will also be protests in Austin, Texas around Tesla's robotaxi demonstrations.
Moving on from physical protests at Tesla dealerships, Sheridan said attention may turn to economic efforts like getting pension funds to divest their Tesla stock. Sheridan also cautioned that Musk "still has a ton of power" and is threatening to launch and/or fund a third political party.
Sheridan said the goal is to continue to convince the billionaires that politics is not for them.
"Let the democratic process play out."
<h3 class="wp-block-heading">What's Next for Tesla</h3>
Sheridan warns that things could worsen for Tesla, considering Musk has fewer customers to sell to.
After catering to the left side of the political spectrum, Musk's behavior has alienated them and led to a hatred for Tesla. His campaigning catered to the MAGA (Make America Great Again) base of Trump supporters. However, if Musk is on the outs with Trump, he may be out of options. 
"Who's left? He's made enemies everywhere,&#8221; Sheridan said.
While not an analyst, Sheridan said Tesla stock price seems high given the constant flow of bad news <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45818240/tesla-stock-faces-demand-brand-issues-in-us-competition-in-china-analyst-lowers-delivery-estimates">and disappointing sales figures</a>.
Price Action: Tesla stock was up 3.7% to $295.14 on Friday. Tesla shares are down 14% over the last five days and down 22% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/44963440/tesla-takedown-says-protests-are-working-hitting-ev-company-where-it-hurts-the-companys-bottom-line">Tesla Takedown Says Protests Are Working: Hitting Where It Hurts, &#8216;The Company&#8217;s Bottom Line&#8217;</a></li>
</ul>
Image: Shutterstock

Politics

Exclusives

Interview

TSLA

EXCLUSIVE: Trump Can 'Hurt Elon's Businesses,' Says Tesla Protest Organizer — But At This Point 'Who's Left' To Buy?

Cyngn Donald Alvarez Steps Down As CFO And Board Member; Natalie Russell Appointed Interim CFO Effective June 6, 2025,

ROLR

High Roller Reveals Letter Of Non-Compliance With NYSE American Continued Listing Standards Received On On June 4, 2025

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 15 years by 4.43% on an annualized basis producing an average annual return of 16.43%. Currently, CACI International has a market capitalization of $9.80 billion. 
Buying $100 In CACI: If an investor had bought $100 of CACI stock 15 years ago, it would be worth $977.08 today based on a price of $445.45 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749244513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI

$100 Invested In CACI International 15 Years Ago Would Be Worth This Much Today

VERO

On June 5, 2025, Venus Concept  Entered Into A Unit Purchase Agreement With Meta Robotics And MHG Co. Pursuant To Which The Company Agreed To Sell The Venus Hair Business To Meta Healthcare Group In An All-Cash Transaction Valued At $20M

SKYX

SKYX Platforms Files For Resale Of 3.5M Shares Of Common Stock By Selling Securityholders

<h3>Gainers</h3>
<ul>
<li>Lazydays Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GORV#NASDAQ">GORV</a>) shares increased by 13.6% to $0.29 during Friday's after-market session. The company's market cap stands at $32.0 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) shares rose 12.23% to $1.19. The company's market cap stands at $16.3 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) shares moved upwards by 11.99% to $2.8. The company's market cap stands at $7.0 million. </li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock increased by 9.99% to $1.98. The market value of their outstanding shares is at $38.9 million. </li>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares increased by 7.71% to $6.0. The company's market cap stands at $140.6 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) shares moved upwards by 7.17% to $0.89. The market value of their outstanding shares is at $17.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) stock fell 26.2% to $5.06 during Friday's after-market session. The market value of their outstanding shares is at $111.5 million. As per the press release, Q1 earnings came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock decreased by 11.19% to $1.35. The company's market cap stands at $22.1 million. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) stock fell 10.21% to $2.2. The company's market cap stands at $6.7 million. </li>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAT#NASDAQ">FAT</a>) shares fell 9.99% to $2.24. The market value of their outstanding shares is at $39.8 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSA#NASDAQ">VSA</a>) shares fell 9.67% to $0.93. The market value of their outstanding shares is at $9.2 million. </li>
<li>Neo-Concept International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) stock decreased by 9.13% to $0.35. The company's market cap stands at $7.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

GDHG

GORV

NAAS

PLCE

RIME

YSXT

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Pheton Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTHL#NASDAQ">PTHL</a>) shares rose 8.2% to $14.61 during Friday's after-market session. The market value of their outstanding shares is at $211.8 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares rose 6.67% to $0.43. The company's market cap stands at $1.8 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) stock rose 6.66% to $3.2. The market value of their outstanding shares is at $5.2 million. </li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock rose 6.38% to $1.64. The market value of their outstanding shares is at $27.8 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) shares increased by 6.25% to $0.82. The company's market cap stands at $27.1 million. </li>
<li>Femasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEMY#NASDAQ">FEMY</a>) stock rose 6.24% to $0.85. The market value of their outstanding shares is at $23.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) shares decreased by 22.2% to $4.18 during Friday's after-market session. The company's market cap stands at $2.1 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) stock decreased by 9.93% to $2.45. The market value of their outstanding shares is at $6.3 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) stock decreased by 9.81% to $0.46. The company's market cap stands at $9.4 million. </li>
<li>Liminatus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) stock declined by 9.58% to $22.0. The market value of their outstanding shares is at $572.3 million. </li>
<li>Know Labs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KNW#AMEX">KNW</a>) shares decreased by 8.32% to $1.43. The company's market cap stands at $10.7 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) shares fell 7.48% to $3.96. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABVC

APDN

FEMY

GTBP

JUNS

LIMN

NUWE

OGEN

PTHL

TCRT

TLPH

12 Health Care Stocks Moving In Friday's After-Market Session

Bowhead Specialty Files For Mixed Shelf Of Up To $300M

<h3>Gainers</h3>
<ul>
<li>Northann (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NCL#AMEX">NCL</a>) shares rose 34.0% to $0.35 during Friday's after-market session. The company's market cap stands at $19.3 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock rose 9.47% to $0.44. The market value of their outstanding shares is at $63.3 million. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock rose 8.78% to $2.6. The company's market cap stands at $50.1 million. </li>
<li>Vertical Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTL#NYSE">EVTL</a>) stock rose 6.5% to $5.73. The company's market cap stands at $484.4 million. </li>
<li>Archer Aviation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NYSE">ACHR</a>) shares rose 6.47% to $10.85. The market value of their outstanding shares is at $5.9 billion. </li>
<li>Cycurion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCU#NASDAQ">CYCU</a>) stock moved upwards by 5.76% to $0.43. The company's market cap stands at $13.6 million. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Armlogi Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOC#NASDAQ">BTOC</a>) stock decreased by 13.2% to $1.12 during Friday's after-market session. The company's market cap stands at $47.1 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares fell 8.38% to $3.49. The company's market cap stands at $9.4 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 7.29% to $0.27. The company's market cap stands at $61.7 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock declined by 5.01% to $0.43. The market value of their outstanding shares is at $7.8 million. </li>
<li>Nixxy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) stock declined by 4.77% to $2.2. The company's market cap stands at $42.1 million. </li>
<li>ZJK Industrial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) shares fell 4.45% to $4.73. The company's market cap stands at $290.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACHR

BTOC

CYCU

EVTL

ILAG

LNZA

Nuveen Insured California Premium Fund Ii

NIXX

SCWO

SRFM

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 11.3% to $0.73 during Friday's after-market session. The market value of their outstanding shares is at $5.1 million. </li>
<li>Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) stock rose 8.33% to $79.0. The market value of their outstanding shares is at $11.9 billion. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) stock increased by 6.15% to $1.7. The market value of their outstanding shares is at $35.7 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) shares moved upwards by 5.8% to $0.42. The company's market cap stands at $11.0 million. </li>
<li>Forward Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORD#NASDAQ">FORD</a>) stock rose 4.92% to $6.82. The market value of their outstanding shares is at $7.5 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) stock increased by 3.47% to $2.68. The market value of their outstanding shares is at $56.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) stock decreased by 6.3% to $3.29 during Friday's after-market session. The market value of their outstanding shares is at $32.1 million. </li>
<li>SiTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SITM#NASDAQ">SITM</a>) stock fell 5.0% to $195.55. The company's market cap stands at $4.6 billion. </li>
<li>Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) shares fell 4.55% to $8.2. The company's market cap stands at $95.5 million. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock decreased by 4.17% to $1.15. The company's market cap stands at $5.8 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares decreased by 4.11% to $3.5. The company's market cap stands at $5.3 million. </li>
<li>BIO-key International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) shares fell 4.08% to $0.82. The company's market cap stands at $4.7 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKYI

BTCS

CLRO

DUOT

ENTG

FORD

MOVE

PRSO

SITM

SOBR

VRAR

12 Information Technology Stocks Moving In Friday's After-Market Session

Press Releases

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

Health Care

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

IPOs

Xilio Therapeutics Announces Proposed Public Offering

Financing

Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Aligos Therapeutics

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

CAMP4 Therapeutics Corporation - Common Stock

Camp4 Therapeutics

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Clene

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Dyadic International, Inc. - Common Stock

Dyadic International

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroBiologics

FibroGen

MiNK Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Kezar Life Sciences

Lantern Pharma

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Passage Bio

Pluri

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Vor Biopharma

Raymond James

Chardan Capital

Morgan Stanley

Comments

Xilio Therapeutics

Noticias

Últimas noticias sobre Xilio Therapeutics (NASDAQ:XLO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL